One of the Jersey Shore’s largest orthopedic groups has announced that it will be joining forces with the Rothman Institute. The partnership will be marketed as Brielle Orthopedics at Rothman and adds 14 new physicians and three new offices to Rothman’s portfolio.
Brielle Orthopedics Joins Rothman Institute

Brielle Orthopedics has been in operation for over 50 years and provides services in general orthopedics, non-operative spine care, operative spine, physical therapy, and diagnostic procedures for musculoskeletal disorders.
Rothman Orthopaedic Institute is a private orthopedic practice dedicated to providing communities with high-quality, compassionate, and affordable musculoskeletal care that is grounded in evidence-based medicine, the results of which will exceed expectations. Rothman Orthopaedic Institute orthopedists treat patients at over 36 locations in Pennsylvania, New Jersey, and New York.
Bruce D. Stamos, M.D., Sports Medicine surgeon at Brielle Orthopedics said, “The physicians and staff of Brielle Orthopedics are excited about our partnership with Rothman Orthopaedic Institute…. The musculoskeletal health care marketplace is changing and bringing these two groups together to meet this test will benefit our patients now, and in the future.”
“We’re delighted to partner with the extraordinary physicians of Brielle Orthopedics,” said Alexander R. Vaccaro, M.D., Ph.D., MBA, President of Rothman Orthopaedic Institute, Richard H. Rothman Professor and Chairman of the Department of Orthopedics, and Professor of Neurosurgery at Thomas Jefferson University and Hospitals. “They have an exceptional reputation in the Eastern New Jersey and shore communities they serve. We look forward to a smooth transition for patients and a bright future working together.”
The physicians now a part of Rothman Orthopaedic Institute are:
Joseph P. Bogdan, M.D.
Raymond E. Esquieres, M.D.
William J. Gallagher, M.D.
Samantha L. Kanarek, D.O.
Brian M. Katt, M.D.
William A. Law, M.D.
Laura A. Malfitano, D.O.
Joseph G. Marsicano, M.D.
Michael N. Nakashian, M.D.
Jason A. Nitche, M.D.
James R. Polowczyk, D.P.M.
David J. Rodricks, M.D.
Thomas G. Sargent, D.O.
Bruce D. Stamos, M.D.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.